CHARLES WYKOFF to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications CHARLES WYKOFF has written about Randomized Controlled Trials as Topic.
Connection Strength
0.473
-
Interpreting results from randomized controlled trials: What measures to focus on in clinical practice. Eye (Lond). 2023 10; 37(15):3055-3058.
Score: 0.142
-
Noncompliance in Prospective Retina Clinical Trials: Analysis of Factors Predicting Loss to Follow-up. Am J Ophthalmol. 2020 02; 210:86-96.
Score: 0.112
-
Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T. Ophthalmic Surg Lasers Imaging Retina. 2015 Mar; 46(3):302-5.
Score: 0.081
-
Exploring the fragility of meta-analyses in ophthalmology: a systematic review. Eye (Lond). 2024 Nov; 38(16):3153-3160.
Score: 0.039
-
Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis. Eye (Lond). 2023 01; 37(1):6-16.
Score: 0.033
-
Supplemental Scleral Buckle for the Management of Rhegmatogenous Retinal Detachment by Pars Plana Vitrectomy: A Meta-Analysis of Randomized Controlled Trials. Ophthalmologica. 2022; 245(2):101-110.
Score: 0.032
-
Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER Data. Am J Ophthalmol. 2022 04; 236:12-19.
Score: 0.032